TR200907237A2 - Tiotropium dry powder combination - Google Patents
Tiotropium dry powder combinationInfo
- Publication number
- TR200907237A2 TR200907237A2 TR2009/07237A TR200907237A TR200907237A2 TR 200907237 A2 TR200907237 A2 TR 200907237A2 TR 2009/07237 A TR2009/07237 A TR 2009/07237A TR 200907237 A TR200907237 A TR 200907237A TR 200907237 A2 TR200907237 A2 TR 200907237A2
- Authority
- TR
- Turkey
- Prior art keywords
- dry powder
- powder combination
- tiotropium
- tiotropium dry
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş, solunum yolları rahatsızlıklarında kullanılmak üzere, tiotropium aktif maddesinin etkili miktarlardaki kromolin türevi bir madde ile birlikte formüle edildiği inhalasyon yoluyla kullanılacak bir ilaç bileşimine dairdir.The present invention relates to a pharmaceutical composition for use by inhalation in which the active agent tiotropium is formulated together with an effective amount of a cromolyn derivative for use in respiratory diseases.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2009/07237A TR200907237A2 (en) | 2009-09-23 | 2009-09-23 | Tiotropium dry powder combination |
PCT/TR2010/000184 WO2011037550A2 (en) | 2009-09-23 | 2010-09-22 | Dry powder combination of tiotropium |
EP10787588A EP2480287A2 (en) | 2009-09-23 | 2010-09-22 | Dry powder combination of tiotropium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2009/07237A TR200907237A2 (en) | 2009-09-23 | 2009-09-23 | Tiotropium dry powder combination |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200907237A2 true TR200907237A2 (en) | 2011-04-21 |
Family
ID=43643869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2009/07237A TR200907237A2 (en) | 2009-09-23 | 2009-09-23 | Tiotropium dry powder combination |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2480287A2 (en) |
TR (1) | TR200907237A2 (en) |
WO (1) | WO2011037550A2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8712251D0 (en) * | 1987-05-23 | 1987-07-01 | Fisons Plc | Formulation |
DE3931041C2 (en) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
GB9006233D0 (en) | 1990-03-20 | 1990-05-16 | Kenrick & Jefferson Ltd | Forms,for use,for example,as parking tickets |
CN1150890C (en) | 1998-08-04 | 2004-05-26 | 杰格研究股份公司 | Medicinal aerosol formulations |
GB0009592D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
NZ526024A (en) * | 2000-10-31 | 2005-10-28 | Boehringer Ingelheim Pharma | Inhalative propellant-free solution formulation containing a tiotropium salt |
WO2006076222A2 (en) * | 2005-01-10 | 2006-07-20 | Glaxo Group Limited | Pharmaceutical formulations |
-
2009
- 2009-09-23 TR TR2009/07237A patent/TR200907237A2/en unknown
-
2010
- 2010-09-22 EP EP10787588A patent/EP2480287A2/en not_active Withdrawn
- 2010-09-22 WO PCT/TR2010/000184 patent/WO2011037550A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2480287A2 (en) | 2012-08-01 |
WO2011037550A2 (en) | 2011-03-31 |
WO2011037550A3 (en) | 2011-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2009003236A (en) | REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HEMATOLOGICAL DISEASES | |
RS54310B1 (en) | Inhalation composition containing aclidinium for treatment of asthma | |
EA201291306A1 (en) | COMPOSITION OF DRY POWDER CONTAINING ANTIMUSCARINE MEANS | |
ECSP13012612A (en) | DERIVATIVES OF QUINAZOLIN-4- (3H) -ONA USED AS INHIBITORS OF P13 CINASA | |
HN2010001920A (en) | DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF- PROPIL-4-HYDROXYLASE | |
MX2011011733A (en) | Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds. | |
RS54241B1 (en) | Inhalation composition containing aclidinium for treatment of chronic obstructive pulmonary disease | |
TR201008226A2 (en) | An inhalation device containing capsules. | |
CU20100111A7 (en) | 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE FOR THE TREATMENT AND PREVENTION OF PULMONARY AND CARDIOVASCULAR DISEASES | |
UA111628C2 (en) | COMPOSITION FOR PLANT DISEASE AND ITS APPLICATION | |
TR200803522A1 (en) | Easy to use inhalation device. | |
CU20130072A7 (en) | 1 H-PIRAZOL-5-SUBSTITUTED SODIUM OLATO | |
TR201000733A2 (en) | Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate. | |
BRPI1005932A2 (en) | compound, pharmaceutical composition for inhalation and inhaler | |
TR200907917A2 (en) | Dry powder inhaler. | |
PH12016500577A1 (en) | Piperazine derivatives and the use thereof as medicament | |
TR201205852A2 (en) | Improved new dry powder formulation. | |
TR200909792A2 (en) | Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative | |
TR200907237A2 (en) | Tiotropium dry powder combination | |
TR200803525A2 (en) | Powder inhaler. | |
TR200909790A2 (en) | Combination of dry powder containing a combination of tiotropium, formoterol and a chromoglycic acid derivative. | |
TR201105367A2 (en) | A dry powder formulation with improved flow properties. | |
TR200909789A2 (en) | Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination | |
TR200909788A2 (en) | Dry powder formulation suitable for inhalation with tiotropium | |
TR200909793A2 (en) | Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative. |